Clinical Trial Update: Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Oncaspar (pegaspargase), Doxil (liposomal doxorubicin), and Decadron (dexamethasone) in refractory lymphoid malignancies; the study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Decadron (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Oncaspar (pegaspargase)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Non-hodgkins Lymphoma, Hodgkins Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2014-08-20